Combinatorial approaches to the prevention and treatment of HIV-1 infection
about
Current perspectives on HIV-1 antiretroviral drug resistanceAn overview of the synthetic routes to the best selling drugs containing 6-membered heterocyclesSystematic analysis of cell cycle effects of common drugs leads to the discovery of a suppressive interaction between gemfibrozil and fluoxetineDrug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxisSHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant virusesCharacterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco.Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicidesHybrid compounds: from simple combinations to nanomachines.Targeting RNA-protein interactions within the human immunodeficiency virus type 1 lifecycle.Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitors.Impact of Tat Genetic Variation on HIV-1 DiseaseControlling the hydration rate of a hydrophilic matrix in the core of an intravaginal ring determines antiretroviral releaseEfficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicidesGlycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeuticsTranslation of biomedical prevention strategies for HIV: prospects and pitfalls.Evaluation of Combinations of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine with Clinically Used Antiretroviral Drugs.Development of a chimeric c-Src kinase and HDAC inhibitorUsing glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention.HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial.Protein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future direction.IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy.Pharmacokinetics of fixed-dose combination of tenofovir disoproxil fumarate, lamivudine, and efavirenz: results of a randomized, crossover, bioequivalence study.Pharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque Model.Development and characterization of a long-acting nanoformulated abacavir prodrugPre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.
P2860
Q26852626-EE75ED03-C165-4CFB-80F6-4D14D2B2FB83Q28301501-C6B3CBEC-91A1-41E4-B278-0D1F8C5514C3Q28483176-88E9452F-8DE7-4663-B3DA-06E6113A0091Q28486428-98360016-F4C0-485D-A66D-4A4856C78EAEQ28742018-60BFB30D-E8EC-4CAB-97D4-2570371A205EQ33957908-66652991-63FA-4D38-83E2-9550869A48F1Q34005632-ACAB8CF6-71D8-4E3A-8CE4-39EDA12CE531Q34125590-6E08363B-2E63-4BC8-8DB1-F7AEB555C797Q35073452-67B37A11-8863-4896-9ABE-69FE11DDE9AFQ35689392-F99B7A14-D04B-4FB3-8951-F329072EBC54Q36148507-12A46BCC-5176-4ADB-A3FB-3160B59E1101Q36666807-3E8A9723-85D8-4978-89C8-A96CBE6D679AQ36785795-A631C8C5-E128-4D6D-B6E4-1C92166B5B76Q36866689-B34BB710-3F93-4361-BDA1-637906AA2B9BQ37051717-945ED0AD-C7DD-4997-9560-025F109DFBDBQ37124096-54C65A3B-7B6E-40AF-97DA-F1BDCC411835Q37149317-8C9B355C-7EA1-4743-A37B-BDC65E8AB12AQ37458024-A5407A23-5E43-4F2A-9005-3A8C53F018CAQ37593498-C1FA41E0-46C1-4764-ADB9-E6C34BBE33FDQ38574172-471718E4-D9EA-4F33-9F7E-A084EF1F78CBQ38801997-9F820EA9-AE46-4C90-9185-83A5C0FBE217Q39673548-A95ADEB9-B33E-483F-B3C3-128B85452BB5Q40239519-0A2EE225-02E9-4026-9102-618616E7D253Q41280373-7698C1D8-DCD4-4CE1-B77E-F4DB014E331EQ42213704-9F97F474-0C0A-4B7A-A1BE-5CEE434AD13C
P2860
Combinatorial approaches to the prevention and treatment of HIV-1 infection
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Combinatorial approaches to the prevention and treatment of HIV-1 infection
@ast
Combinatorial approaches to the prevention and treatment of HIV-1 infection
@en
type
label
Combinatorial approaches to the prevention and treatment of HIV-1 infection
@ast
Combinatorial approaches to the prevention and treatment of HIV-1 infection
@en
prefLabel
Combinatorial approaches to the prevention and treatment of HIV-1 infection
@ast
Combinatorial approaches to the prevention and treatment of HIV-1 infection
@en
P2093
P2860
P356
P1476
Combinatorial approaches to the prevention and treatment of HIV-1 infection
@en
P2093
Brian Wigdahl
Fred C Krebs
Jeffrey M Jacobson
Nina Thakkar
Vanessa Pirrone
P2860
P304
P356
10.1128/AAC.00976-10
P407
P577
2011-02-22T00:00:00Z